Non-specific Response to H1N1 Vaccine
NCT01178918 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 14
Last updated 2020-02-28
Summary
This is a prospective observational study with recruitment of healthy volunteers from consecutive recipients of H1N1 influenza vaccine at the University Clinic of Respiratory and Allergic Diseases, Golnik, Slovenia.
The purpose of this study is to evaluate certain safety aspects of adjuvanted influenza H1N1 vaccines.
Conditions
- Influenza H1N1
Sponsors & Collaborators
-
The University Clinic of Pulmonary and Allergic Diseases Golnik
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2009-11-30
- Primary Completion
- 2010-12-01
- Completion
- 2012-07-01
Countries
- Slovenia
Study Locations
More Related Trials
-
Safety and Immunogenicity of Two Adjuvanted and One Non-adjuvanted H5N1 Influenza Vaccine in Adults
NCT00382187 ·Status: COMPLETED ·Phase: PHASE2
-
Immunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine in Healthy Subjects 18 or More Years of Age
NCT00970177 ·Status: COMPLETED ·Phase: PHASE3
-
Immune Responses to H5N1 Vaccine With and Without AS03 Adjuvant
NCT01578317 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effectiveness of H1N1 Influenza Vaccines in Manitoba, Canada
NCT01622491 ·Status: UNKNOWN
-
CSL H1N1 Influenza Vaccine Administered at Different Dose Levels With and Without AS03 Adjuvant in Healthy Adult and Elderly Populations
NCT00964951 ·Status: WITHDRAWN ·Phase: PHASE2
-
Immunogenicity and Safety Study of Inactivated Subunit H5N1 Influenza Vaccine in Prior Recipients of Live Attenuated H2N2, H6N1 and H9N2 Influenza Vaccines and in H5N1 and Live Attenuated Vaccine Naïve Individuals
NCT03816878 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) in Adults
NCT00951041 ·Status: COMPLETED ·Phase: PHASE2
-
Observational Study to Assess Safety of H1N1 Pandemic Influenza Vaccine
NCT00950456 ·Status: COMPLETED
-
H5N8 Mix and Match With or Without AS03 or MF59 in Healthy Adults: Immunology
NCT03014310 ·Status: COMPLETED ·Phase: PHASE1
-
Immune Response Study of Influenza Vaccine
NCT01310374 ·Status: COMPLETED
-
A/H1N1 Immunogenicity and Safety in Adults
NCT00959465 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efficacy of FLU-v in an H1N1 Influenza Human Challenge Model
NCT03180801 ·Status: COMPLETED ·Phase: PHASE2
-
Immunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine in Healthy Subjects 18 or More Years of Age
NCT00971906 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Efficacy, Safety and Immunogenicity of Influenza Vaccine in Healthy Subjects (Aged 6 to <72 Months) Versus Control Vaccines
NCT00644059 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of the Effectiveness of Vaccination With 2009 H1N1 Vaccines During Influenza Season 2010-11
NCT01206114 ·Status: COMPLETED
-
Immunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine in Healthy Subjects From 6 Months to 17 Years of Age
NCT00971100 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Immunogenicity of H5N1 Adjuvanted, Inactivated, Split-Virion Pandemic Influenza Vaccine in Healthy Adults
NCT00457509 ·Status: COMPLETED ·Phase: PHASE1
-
Young Adult Influenza Vaccine Immunogenicity Substudy
NCT00170508 ·Status: COMPLETED ·Phase: NA
-
A Study for Evaluation of Immunogenicity and Reactogenicity of FluarixTM / Influsplit SSW® 2009/2010 in Adults
NCT00920374 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine, Fluarix®/Influsplit SSW® (2013/2014 Season), in Adults 18 Years of Age and Older
NCT01884519 ·Status: COMPLETED ·Phase: PHASE3
-
Study of the Safety, Tolerability and Immunogenicity of an Intranasal Influenza Vaccine Administered to Healthy Adults
NCT03293732 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability and Immunogenicity of Two Doses of Adjuvanted Monovalent Influenza Vaccine Administered to Healthy Adult and Elderly Subjects
NCT00841763 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2007/2008) When Administered to NON Elderly AND Elderly Subjects
NCT00518726 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Immunogenicity of Two Doses, Administered Three Weeks Apart, of Two(Surface Antigen Adjuvanted With MF59C.1) Influenza Vaccines in Non-Elderly Adult and Elderly Subjects
NCT00311480 ·Status: COMPLETED ·Phase: PHASE2
-
A Laboratory Evaluation of the Humoral Immune Response in Adults and Children to the H1 Hemagglutinin (HA) Stalk Domain and Other Influenza A Virus Protein Epitopes, After Administration of GlaxoSmithKline (GSK) Biologicals' Pandemic Influenza Vaccines
NCT02415842 ·Status: COMPLETED